Top Markets
Coin of the day
Redx Pharma Plc Redx Pharma Plc

Redx Pharma Plc

REDX
Rankning i aktier #38811
Redx Pharma Plc, established in the United Kingdom in 2010 and headquartered in... Redx Pharma Plc, established in the United Kingdom in 2010 and headquartered in Macclesfield, concentrates its efforts on the discovery, early-stage preclinical development, and licensing of innovative small molecule drugs. The company primarily targets significant unmet medical needs in the therapeutic areas of oncology and fibrosis. Within its oncology portfolio, Redx is progressing RXC004, a porcupine inhibitor currently undergoing Phase II clinical evaluation for treating cancers driven by Wnt-ligands. Additionally, it maintains a research collaboration with Jazz Pharmaceuticals plc, aiming to identify and advance new drug candidates for two specific cancer pathways: the Ras/Raf/MAP kinase pathway. For fibrotic conditions, Redx Pharma is developing several compounds, including RXC007, an oral selective ROCK2 inhibitor intended for the treatment of various fibrotic diseases. Its pipeline also features a gastrointestinal-targeted ROCK inhibitor specifically designed to address fibrosis associated with Crohn's disease, along with a discoidin domain receptors (DDRs) inhibitor for a range of fibrotic disorders. Furthermore, the company is developing RXC006, another porcupine inhibitor, focused on combating fibrotic illnesses such as idiopathic pulmonary fibrosis.
Aktiekurs
$0.20410523
Senast synkroniserad: 2024-04-30
Marknadsvärde
$793.94K
Förändring (1 dag)
42.54%
Förändring (1 år)
0.00%
Land
GB
Handel Redx Pharma Plc (REDX)

Kategori

Aktiekurshistorik för Redx Pharma Plc (REDX)
Högsta slutkurs: $0.12 den 2024-04-01

Lägsta slutkurs: $1.26 den 2015-03-01
Aktiekurshistorik för Redx Pharma Plc från 2015 till 2026
Årlig aktiekursutveckling
År Prestanda
2024 -59.88%
2023 -59.57%
2022 -25.78%
2021 29.62%
2020 711.52%
2019 9.53%
2018 -70.73%
2017 -45.20%
2016 -51.74%
2015 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$507.52 30.03%
US
$847.62 29.92%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE